First Chinese PD-1 Inhibitor Hetronifly® (serplulimab) Recommended by NICE for NHS Lung Cancer Care
UK's NICE recommends China's serplulimab (trade name in Europe: Hetronifly) for routine use within the National Health Service (NHS) in England and Wales SHANGHAI, CHINA, August 30, 2026 /EINPresswire.com/ -- A pioneering immune …